Metabical Case Solutions

In: Business and Management

Submitted By awweeden
Words 1464
Pages 6
Andrew Weeden, Jason Giest, Kerri Kuhn
Group 12
Metabical Case
Current Competition

Metabical is the “first and only prescription weight loss drug to receive FDA approval.” This prescription drug has less side affects than current weight loss options, which creates a market niche because if people are not obese but want to lose 10-30 pounds they might consider it if the negative affects are subtle. CSP is targeting overweight people (BMI between 25 and 30) not obese or sever obese people (BMI >30 or BMI >40), which is different from other weight loss drugs. They were able to do this by combining the “2 categories of prescription diet drugs: appetite suppressants and fat-absorbing blockers” in a dual layer pill. “The first layer contained an appetite suppressant, calosera, while the second layer contained a fat blocker and calorie absorption agent, meditonan.” These drugs worked in low dose levels, which created less negative affect on the body. Prescription drugs often have side effects but Metabical has no side effects associated with it, which is another major selling point for CSP. Some of the side effects listed for Metabical’s competition were serious enough to cause long term damage such as liver failure, kidney stones, severe stomach pain and gallbladder disease. Some of the major side effects were even life threatening. Not killing the customer is always a good strategy and encourages repeat business. The formula used for Metabical is also an advantage, the two-stage pill uses low levels of chemicals so that there are no harmful side effects, it suppresses appetites while simultaneously releasing a fat blocker. Basically Metabical advantage is its safeness compared to other weight-loss drugs.

Demand Forecast

Forecast Method 1: Targets the entire overweight population
Pros: This method does not take a sample but it takes the whole overweight…...

Similar Documents

Case Solution

...the romance must inform their supervisors of the relationship. * romance cannot/should not be between employee and client/customer. * those involved in the romance may/should not report to the same supervisor. * romance cannot/should not be between employees of a significant rank difference. * those involved in the romance may/should not work on the same projects. * workplace romances are not/should not be permitted at our/any organization. * romance cannot/should not be between employee and a vendor. * romance cannot/should not be between employee and employee from a competitor. When SHRM surveyed HR personnel and employees about the consequences of such fraternization the results weren’t equal. In all cases HR personnel favored more harsh penalties for office romance. CONSEQUENCES FOR EMPLOYEES IN WORKPLACE ROMANCES Source: 2001 SHRM®/ Workplace Romance Survey Of the HR professionals surveyed they felt such behavior should allow for: * transfer within organization * termination * counseling * formal reprimand * suspension * demotion At AppleOne Web site it provides recommendations for companies on how to handle office romance. It outlines four steps that can be taken: Step 1 - If you haven't done so, implement, disseminate and unconditionally enforce policies on dating and family relationships in the workplace to promote uniform treatment of all employees. Have a legal professional review these......

Words: 1427 - Pages: 6

Case Solution

...Lyons Document Storage Corporation Case Analysis 1. Before maturity, a bond may be selling at the face value or at a price greater or lesser than the face value.The terms “premium” and “discount” refer to the difference that exists from the face value of the bond. Bonds selling at a price greater than the face value are said to be at a premium and the bonds selling at a price lesser than the face value are said to be at a discount. Premium or discount occurs when nominal interest rate(or coupon rate) of the bond differs from the current market rate of interest demanded by lenders.Regardless of the required yield, the bond price will reach face value as its approaches the maturity date. The bond with a face value of $1000 is issued at a discount price of $907.992 * The amount received by Lyons from its 8% bonds if the rate prevailing at the time of original issue was 9 % is =$ $907.992*10,000 =9,079,920.78 Present Value of $1 |   | At 8% | Discounted value of the bond at the time of issue At 9% | Received Semiannually for 20 years | 19.79277 | 18.40158 | Received at the end of 20 years | 0.208289 | 0.171929 | P.V. of Coupon Earned | 791.711 | 736.0634 | P.V. of Redemption Value | 208.289 | 171.9287 | Total |   | 1000 | 907.9921 | * The recomputed amount in the balance sheet in December,2006 and December,2007 are $9,258,589.55 and $9,292,611.26. * The current value of the bonds outstanding at the current effective rate of 6% is =......

Words: 982 - Pages: 4

Case Solution

...especially given the lack of direct control from the financing party. 2. Is ADI an environment in which corporate entrepreneurs can thrive? 3. What might you have done differently if you were Mr. Payne? Mr. Fishman? Mr. Weigold? Mr. Stata? 4. Was MEMS a success CASE SOLUTION CASE 5-1 PROFIT CENTER PROBLEMS AMAX Automobiles  AMAX Automobiles was a car company with three product lines. Line A was aimed at the luxury segment, line B at the upscale segment, and line C at the mass market segment. Each of the three product lines was sold under a different brand name and used different distribution systems. Lines A, B, and C were currently produced and marketed by divisions A, B, and C, respectively. Some components were common to the three divisions. Some of these common components were sourced externally while others were manufactured inside the company. Also, there existed considerable scope for technology and know-how transfer across divisions. Specifically, product innovations seemed to originate in division A and then migrate to divisions B and C. However, process innovations seemed to originate in divisions C and then migrate to division A and B. How should AMAX be organized and controlled? Solution: According to our opinion, when organization made divisions, automatically the organization made profit centers, because every divisions has its own jobs and each jobs has been delegated. In each divisions, we make standard and rule of law. So we can controlling the......

Words: 1910 - Pages: 8

Metabical Pricing

...Printup go about segmenting the Metabical market? What do you think is the optimal target market? Segmentation Different segments as identified by Printup, based on different studies conducted can be classified as follows: • Psychographic segmentation It is based on a wide variety of attitudes towards physical activity, portion control, food preferences, nutrition, self-image, and overall health. Five discrete psychographic profiles identified in case of women can be classified as follows: Segment Typical demographic profile I want to look like a movie star Age 18 to 30, high school education, household income under $40,000 I want to be healthier Age 35 to 65, college education plus, household income $80,000+ I want to wear my skinny jeans Age 25 to 40, college education , household income $50,000-$80,000 I want to lose weight, but only if it is easy Age 45 to 65, some college education, household income $40,000-$60,000 I am fine the way I am Age 40 to 65, some college education, household income $30,000-$50,000 • BMI scale classification The customers can also be segmented based on the relationship between their weight and height associated with body fat and health risk and appropriate both for men and women. Three categories of excess weights for adults: overweight (25 to 30); obese (30 to 40); and severely, or morbidly, obese (over 40). • Gender segmentation Both men and women who are overweight can be the segment for Metabical. Targeting a......

Words: 912 - Pages: 4


...eport abuse Transcript of Metabical Case Study Presented by: The Lever Group Metabical - Case Study Goal? Targeting and Positioning: How to market Metabical to the correct audience to maximize sales Who are we? The Lever Group An independent market research group specializing in the balance between exercise and diet for overweight individuals Cambridge Sciences Pharmaceuticals (CSP) International health care company $25 billion in sales in 2007 Makers of Zimistat Metabical - may be first FDA approved prescription drug? Shown to be very effective for slightly overweight individuals The Situation Ideal target customer is a slightly overweight female between the age of 35-65. Positioning Strategy Losing weight is tough. You don't have to do it alone. Let Metabical and your health care provider start you on the road to a healthy weight and better life. (End Consumers) Advertising Message How to Market? TARGET: SWOT ANALYSIS CSP has spent 10 years and $400 million developing Metabical A successful launch will ensure a steady, long-term demand. Not a long term solution for patients Should be combined with diet and exercise Emphasize support program to change behavior patterns with over-eating The Consumer Decision Making Process Empower your patients to lose excess weight, change their unhealthy eating habits, and achieve long term success. Introducing Metabical – short-term drug therapy and a comprehensive support program for overweight patients. It gets......

Words: 342 - Pages: 2


...METABICAL Situational Analysis and SWOT Situational Analysis Item | Issues-Facts | Implications to Situation | SWOT | Organization Structure | | | | 1 | Barbara Printup has over 20 years of experience marketing prescription drugs | Experience helps in the marketing and launch strategy for s new product to market | S | Leadership | | | | 1 | $25B in sales in 2007 | Brand recognition is key | S | 2 | Clinical trials performed to show majority of individuals reached weight-loss goals by week 12 and minimal weight loss after that | By generating data through clinical trials, FDA clearance is a route which is an opportunity over its OTC and supplement competitors | S | Functional Areas | | | | 1 | 10 years of testing and $400 million in R&D costs | A great deal of time and resources invested into product | W | 2 | Researchers at CSP combined an appetite suppressant (calosera) with a fat-blocking agent (meditonan) to for Metabical | The strong R&D team at CSP gives the company a competitive advantage in inventing revolutionary products | S | 3 | Negative side effects occur when users consume high levels of fat and calories | People tend to eat "junk" because they believe diet pills will cancel it out | W | Political, Legal &Ethical | | | | 1 | No prescription-drug options available specifically for the overweight segment (BMI 25-30) | Entering the market first will undoubtedly come with a large market share in the future | O | ...

Words: 2469 - Pages: 10

Case Solution of Process Strategy

...University Malaysia Kelantan (UMK) [pic] Malaysian Graduate School of Entrepreneurship and Business (MGSEB) Course Name: Operations Analysis Course Code: GST-5043 “Case Study on Rochester Manufacturing Company” Submitted To: Prof Madya Dr Isahak Kassim Submitted By: Md. Mojammel Hoque (Matric No.) ROCHESTER MANUFACTURING’S PROCESS DECISION Question #1: As a production manager for RMC, what do you recommend? Why? Solution: Being production manager supposing flexible machining system’s intrinsic compensations must take decisions which have possible favorability towards FMS so that managerial tasks/ missions become easier and consequently becomes healthier because that might linked with managerial responsibility in relation with development, human resource empowerment, continuance, and organization should necessitate less track and easily control over. You would be accountable to inquire the “numbers people” to be certain them incorporated all of these comparatively inconsequential shop floor subjects in the decision. Question #2: Prepare a case by a conservative plant manager for maintaining the status quo until the returns are more obvious. Solution: In this decision making process an individual with conservative frame of mind plant manager is required who could be questioned for ROI. This responsibility of plants manager to talk about ROI is considered on top rank but if numbers don’t support your change requirements......

Words: 347 - Pages: 2

Case Solution

...Problem Statement: How can Gaylord Bates Company lease a machine without reporting the lease as an asset and liability? Solution: There are two classifications of leases, Capital leases and Operating leases. In order for Gaylord Bates to avoid the equipment being put on their balance sheet as an asset, the lease must meet the criteria of an operating lease. In order for the lease to be considered an operating lease it must meet all of the following four criteria: 1) No transfer of ownership at the end of the lease term, 2) No bargain purchase option, 3) the lease term is less than 75% of the estimated 10 year economic life, and 4) the present value of the lease payments ($59,180) is less than 90% of the fair value of the leased property. In order for the lease to meet the final 2 requirements it must be a 7-year lease with a rate of 6% or higher. At 6% the present value of the payments equals $350,187 (87.5% of fair value). Authoritative Citations: The citations used were: FASB ASC 840-10-25-1, FASB ASC 840-10-20, and FASB ASC 840-20-25-1. FASB ASC 840-10-25-1 was used to understand the criteria needed to meet a capital lease. FASB ASC 840-10-20 was used to define the 4 main criteria of a capital lease along with operating leases. FASB ASC 840-20-25-1 explains how expenses are to be accounted for under an operating lease....

Words: 257 - Pages: 2


...Metabical: Pricing, Packaging &Demand Forecasting For A New Weight Loss Drug Metabical: Pricing, Packaging &Demand Forecasting For A New Weight Loss Drug Abstract Metabical will be the only weight loss drug clinically proven to be effective for moderately overweight people, also recognized by the FDA. The CSP’s (Cambridge Sciences Pharmaceuticals) drug Metabical got its final approval from the FDA. The senior marketing director for CSP-Barbara Printup must develop the marketing communication and positioning strategy for a successful launch of the new drug Metabical. The main points to be stressed on by Barbara are consumer decision making concept and understanding between the consumer who is purchasing the drug and the health care provider who prescribes the medicine. Poor positioning of the drug in a highly competitive market for weight loss solutions could prove to be disastrous despite promising medical studies and consumer research. CSP wanted to base their new product comparably to Alli, but felt Metabical could be priced at a premium due to the need of a prescription to get the drug. Pricing was the main concern with this product and several scenarios were run to try and project and forecast where the pricing would give the best returns on investment. Objective * Develop Positioning Strategy for the drug. * Build the marketing communication plan in order to create a strong level of understanding between the consumer and the prescriber of the......

Words: 671 - Pages: 3

Metabical Case

...Reinald Nathaniel 29115153 – Syndicate 1 Metabical Case According to the data and our calculation, there are two methods that could be used to be consider in Metabical’s pricing strategy. First we would narrow the population into a niche market by filtering the numbers. It is done by taking the number of people who tries to lose weight, then the next filter that we put is: to sort out by the number of people who are comfortable in using pills (Method 1). The other method is to get the number from people who wants to consume drugs with prescription (Method 2). Year | Americanswith 25>BMI>30 | Population Trying to Lose Weight (35%) | Comfortable using diet pills (15%) | Medibical Will Capture | Population Captured | Sales | 1 | 71,060,000 | 24,871,000 | 3,730,650 | 10% | 373,065 | 37,300,381.73 | 2 | 71,060,000 | 24,871,000 | 3,730,650 | 15% | 559,598 | 55,950,572.60 | 3 | 71,060,000 | 24,871,000 | 3,730,650 | 20% | 746,130 | 74,600,763.47 | 4 | 71,060,000 | 24,871,000 | 3,730,650 | 25% | 932,663 | 93,250,954.34 | 5 | 71,060,000 | 24,871,000 | 3,730,650 | 30% | 1,119,195 | 111,901,145.20 | | Total sales | 373,003,817.34 | | Total Investment | 488,730,000 | | ROI | -23.68% | METHOD 1: Total investment (marketing costs, manufacturing overhead $ 1.2 million per year, R&D with sunk cost $400 million). ROI = (total sales-total investment)total invesmentx 100% METHOD 2: Year | Americanswith 25>BMI>30(34% overweight) | Population......

Words: 564 - Pages: 3

Case Solutions

...CHAPTER 1 ACCOUNTING: INFORMATION FOR DECISION MAKING OVERVIEW OF BRIEF EXERCISES, EXERCISES AND CRITICAL THINKING CASES Brief Exercises B. Ex. 1.1 B. Ex. 1.2 B. Ex. 1.3 B. Ex. 1.4 B. Ex. 1.5 B. Ex. 1.6 B. Ex. 1.7 B. Ex. 1.8 B. Ex. 1.9 B. Ex. 1.10 Learning Objectives 1, 3, 5 2,5 3,4 5,6 1, 3, 5, 6 5, 6 2, 5, 6 7, 8 5, 7 1 Topic Users of accounting information Components of internal control Inexact or approximate measures Standards for the preparation of accounting information FASB conceptual framework PCAOB COSO Professional certifications in accounting AICPA code of professional conduct Personal benefits of accounting skills Skills Analysis Analysis Analysis, judgment Analysis Analysis Analysis, research Analysis, ethics Analysis Analysis, ethics Analysis Exercises 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 Topic You as a user of accounting information Real World: Boeing Company, California Public Employees Retirement System, China Airlines Users of accounting information What is financial reporting? Generally accepted accounting principles Accounting organizations Investment return Accounting terminology Accounting organizations Financial and management accounting Management accounting information Accounting organizations Purpose of an audit Audits of financial statements Ethics and professional judgment Careers in accounting Home Depot, Inc. general information Learning Objectives Skills 1 Analysis, judgment 3, 4 Analysis,......

Words: 7422 - Pages: 30

Metabical  Business Case

...Pharmaceuticals’ (CSP) newest prescription drug, Metabical. CSP was an international healthcare company with over $25 billion in sales in 2007. Metabical was part of a strategic initiative that would allow CSP to enter the $3.74 billion market for weight-control products in the United States (7). Metabical was target as a prescription (Rx) for use by those looking to shed between 10 to 30 pounds. Initial reviews from the medical community indicate a strong endorsement of Metabical. It should offer moderately overweight adults a medically proven, effective method to reach a desirable weight and improve their overall health. The majority of Metabical trials participants reached their weight-loss goals by week 12. Although pricing had not been finalized, CSP estimated the retail price for the drug would be approximately $3 to $5 per day, with the average course treatment lasting 12 weeks. The primary question in this case is to analyze the market survey done by the company regarding overweight issues in order for us to decide which is the best market segmentation should be target. The second focus in this report is to position the best strategy which we will state the point of parity and point of differences of Metabical and come out with the positioning strategy and target market. The third focus will be the the SWOT analysis of the product which we will state the strengths, weaknesses, opportunities, and threats of Metabical which lead us indeciding which marketing......

Words: 1641 - Pages: 7

Metabical-Case Study

...yo Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug In April 2008, after 10 years of testing and $400 million in research and development costs, Cambridge Sciences Pharmaceuticals’ (CSP) newest prescription drug, Metabical (pronounced Mehtuh-bye-cal), was about to receive its coveted Food and Drug Administration (FDA) approval. CSP was an international healthcare company with over $25 billion in sales in 2007. The company, based in Cambridge, Massachusetts, focused on developing, manufacturing, and marketing products that treated metabolic disorders, gastrointestinal diseases, and immune deficiencies, as well as other chronic and acute medical conditions. Metabical was part of a strategic initiative that would allow CSP to enter the $3.74 billion market for weight-control products in the United States.1 tC CSP’s chief marketing officer, Bernard Long, said of the new product: No Metabical is revolutionary. It will be the first and only prescription drug to receive FDA approval to meet the needs of the millions of individuals struggling with moderate weight-loss goals. Previous prescription weight-loss drugs had negative side effects that, in the agency’s judgment, outweighed the benefits provided to individuals who were not considered obese. Metabical will be approved for use by those looking to shed between 10 to 30 pounds. Initial reviews from the medical community indicate a strong endorsement of Metabical. Our......

Words: 4511 - Pages: 19


...A Case Write Up – Metabical Case Q1. Upon careful analysis of the case study we can summarise the current standing of the Metabical as a snapshot using the 5 Cs before deep-diving into the specific questions posed as follows: A. CUSTOMER: Metabical is a unique prescribed drug for overweight individuals with a BMI of 25 to 30. Essentially this group makes for our customers and consumers. More details of the target segment will follow as we discuss the case B. COMPANY: Metabical is wholly owned by by Cambridge Sciences Pharmaceuticals (CSI) an international pharmaceutical company of repute with a turnover of 25 billion dollars in 2007. C. COMPETITERS: The health and weight loss industry is cluttered with various weight loss drug options available - both prescribed and OTC, herbal remedies and dietary supplements. Meal and diet plans, exercise regimes and weight loss programmes also form the competitive landscape. D. COLLABORATORS: Doctors who prescribe the drug are influencers and we enlist them as our partners and collaborators E. CONTEXT: United States (the market) has an alarming percentage of excess weight population – 65% across ages. It is also a fairly mature market where there is high awareness for weight loss remedies. In fact, the weight loss drug industry is also tarnished by some deceptive media campaigns. There is however a defined need gap for a FDA approved prescribed drug......

Words: 252 - Pages: 2


...METABICAL CASE STUDY REPORT INTRODUCTION Excess weight had become a big crisis in the US, affecting about 65% of the adult population leading to different kinds of health complications. In the past, several manufacturers had introduced various weight loss products like over-the-counter (OTC) drugs, herbal products, supplementary fad diets, etc. All of these have proven to be unsuccessful because of their ineffectiveness, severe side effects and lack of credibility among consumers. At this juncture, Barbara Printup, the Senior Marketing Director of Cambridge Sciences Pharmaceuticals (CSP) wants to introduce CSP’s newest revolutionary prescription drug, Metabical. It is the only FDA approved prescription drug for overweight people, which has minimal side effects and long term benefits. PURCHASING DECISION MAKING PROCESS (Q1) The communication strategy of Metabical targets both the health care provider and the consumer. Depending on the initiators there are two different purchase decision processes in the purchase of Metabical for the overweight problem. 1. For Customer: a. Problem identification: The various health awareness programs, BMI table etc help a health conscious or beauty conscious individual to identify the overweight problem. b. Information search: Once the problem is identified the individual decides on the course of action. He/She may decide to either ignore the problem or work on it. Metabical is interested in the group of individuals who are ready......

Words: 4420 - Pages: 18

Eps12 Younger - Season 4 (2017) | KeepVid APK Modded | Anvil V-Neck Fashion Basic T-Shirt